You have 9 free searches left this month | to do more

lazertinib

Lazertinib is a drug used to treat Carcinoma, Non-Small-Cell Lung, Healthy, Advanced Solid Malignancies, and other conditions. Lazertinib is being actively studied in 9 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
Janssen Research & Development, LLCHosp. Gral. Univ. Gregorio Maranon
Memorial Sloan Kettering Cancer CenterHosp. Univ. Vall D Hebron
Samsung Medical Center
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Recruiting
  • Hepatic Impairment
  • Healthy
  • Lazertinib
  • Kiel, Germany
  • +1 more
2021-12-30
Dec 30, 2021
J
Recruiting
  • Healthy
  • Lazertinib
  • +3 more
  • Salt Lake City, Utah
    PRA Health Sciences
2021-12-30
Dec 30, 2021
J
Completed
  • Healthy
  • Lazertinib
  • +2 more
  • Tempe, Arizona
    Celerion
2021-02-25
Feb 25, 2021
M
Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Recurrent Non Small Cell Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
2021-09-30
Sep 30, 2021
J
Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Lazertinib
  • Duarte, California
  • +8 more
2022-01-04
Jan 4, 2022
J
Recruiting
  • Advanced Solid Malignancies
  • West Hollywood, California
  • +9 more
2022-01-12
Jan 12, 2022
J
Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Lazertinib
  • +3 more
  • Los Angeles, California
  • +82 more
2021-12-30
Dec 30, 2021
J
Recruiting
  • Non-Small-Cell Lung Cancer
  • Duarte, California
  • +100 more
2021-12-30
Dec 30, 2021